US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist

3.560
+0.260+7.88%

Trading May 2 11:47 ET

151.11MMarket Cap-1596P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-39,590.06%-127.16M

5.00%-28.16M

-137.29%-32.87M

-21.82%-34.35M

-5.93%-31.79M

100.38%322K

-42.91%-29.64M

369.00%88.16M

-56.12%-28.19M

-110.91%-30.01M

Net income from continuing operations

-222.91%-93.8M

11.46%-28.03M

-125.02%-18.88M

68.64%-11.95M

-0.53%-34.94M

72.83%-29.05M

-11.91%-31.66M

344.27%75.46M

-44.79%-38.09M

-62.29%-34.76M

Operating gains losses

126.17%78K

110.29%7K

111.70%11K

93.75%-6K

265.00%66K

-927.78%-298K

-361.54%-68K

-508.70%-94K

-442.86%-96K

2.44%-40K

Depreciation and amortization

-1.37%1.95M

11.21%506K

2.89%498K

-3.25%506K

-14.53%441K

34.47%1.98M

23.64%455K

31.17%484K

26.94%523K

60.25%516K

Deferred tax

----

--0

----

-55.03%-1.25M

-186.28%-1.29M

-655.75%-1.32M

Other non cash items

-0.54%2.19M

-1.07%557K

-0.18%551K

-0.37%545K

-0.55%541K

17.78%2.21M

-9.92%563K

10.40%552K

45.09%547K

46.63%544K

Change In working capital

-787.64%-55.18M

8.17%-5.9M

-324.24%-19.55M

-605.69%-27.62M

-883.70%-2.12M

67.54%8.03M

-645.33%-6.42M

253.14%8.72M

16.76%5.46M

-94.16%270K

-Change in receivables

84.40%-216K

-108.23%-775K

114.86%1.55M

11,586.67%1.75M

-578.47%-2.74M

-146.20%-1.39M

7,020.59%9.41M

-424.74%-10.41M

101.76%15K

-151.86%-404K

-Change in prepaid assets

63.41%969K

1,066.27%802K

43.61%-1.35M

-72.07%188K

-44.56%1.33M

1,953.13%593K

-103.47%-83K

66.00%-2.4M

-63.14%673K

-14.20%2.4M

-Change in payables and accrued expense

-517.87%-9.98M

352.33%5.64M

-19,487.36%-17.04M

-100.14%-8K

256.69%1.43M

-79.79%2.39M

-132.74%-2.23M

87.71%-87K

32.53%5.62M

-162.21%-912K

-Change in other current assets

13.48%101K

--1K

--11K

--0

--89K

129.87%89K

--0

--89K

--0

-Change in other current liabilities

-45.13%-2.22M

-43.80%-568K

-17.12%-554K

-114.73%-554K

-34.81%-546K

-50.10%-1.53M

-50.76%-395K

-90.73%-473K

1.15%-258K

-62.65%-405K

-Change in other working capital

-656.95%-43.83M

16.21%-11M

-109.78%-2.16M

-4,170.99%-29M

-311.03%-1.68M

190.66%7.87M

-64.92%-13.12M

8,042.81%22.08M

-143.37%-679K

-145.78%-408K

Cash from discontinued investing activities

Operating cash flow

-39,590.06%-127.16M

5.00%-28.16M

-137.29%-32.87M

-21.82%-34.35M

-5.93%-31.79M

100.38%322K

-42.91%-29.64M

369.00%88.16M

-56.12%-28.19M

-110.91%-30.01M

Investing cash flow

Cash flow from continuing investing activities

144.40%78.04M

-6.40%31.88M

111.73%24.5M

2,265.78%28.35M

-1,759.06%-6.69M

-10,387.95%-175.78M

8,657.29%34.06M

-53,609.51%-208.93M

-1,018.80%-1.31M

152.20%403K

Net PPE purchase and sale

-221.93%-1.94M

-123.14%-398K

--0

32.12%-1.07M

2.46%-475K

63.52%-602K

1,476.00%1.72M

17.90%-266K

-265.73%-1.57M

36.92%-487K

Net investment purchase and sale

145.66%79.98M

-0.19%32.28M

111.74%24.5M

11,213.46%29.42M

-797.87%-6.21M

-673,653.85%-175.18M

11,945.42%32.34M

-320,921.54%-208.66M

-16.67%260K

--890K

Cash from discontinued investing activities

Investing cash flow

144.40%78.04M

-6.40%31.88M

111.73%24.5M

2,265.78%28.35M

-1,759.06%-6.69M

-10,387.95%-175.78M

8,657.29%34.06M

-53,609.51%-208.93M

-1,018.80%-1.31M

152.20%403K

Financing cash flow

Cash flow from continuing financing activities

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-99.08%880K

-99.83%165K

-25.90%269K

-54.34%205K

31.69%241K

Proceeds from stock option exercised by employees

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-30.65%880K

-39.78%165K

-25.90%269K

-54.34%205K

31.69%241K

Cash from discontinued financing activities

Financing cash flow

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-99.08%880K

-99.83%165K

-25.90%269K

-54.34%205K

31.69%241K

Net cash flow

Beginning cash position

-52.30%159.52M

-30.81%107.37M

-58.11%115.54M

-60.19%121.46M

-52.30%159.52M

2.46%334.43M

-40.54%155.19M

-6.13%275.83M

-2.08%305.14M

2.46%334.43M

Current changes in cash

72.35%-48.28M

-16.53%3.83M

93.29%-8.09M

79.67%-5.96M

-29.62%-38.06M

-2,259.26%-174.58M

-93.75%4.59M

-267.40%-120.5M

-65.28%-29.3M

-98.18%-29.36M

Effect of exchange rate changes

106.67%22K

127.73%71K

37.86%-87K

880.00%39K

-101.41%-1K

-511.11%-330K

-4,366.67%-256K

-137.29%-140K

85.71%-5K

108.82%71K

End cash Position

-30.25%111.27M

-30.81%107.37M

-58.11%115.54M

-60.19%121.46M

-52.30%159.52M

-40.54%155.19M

-6.13%275.83M

-2.08%305.14M

Free cash flow

-46,005.71%-129.1M

-2.28%-28.55M

-137.40%-32.87M

-18.98%-35.41M

-5.80%-32.26M

99.68%-280K

-33.55%-27.92M

365.56%87.89M

-60.99%-29.76M

-103.30%-30.49M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-39,590.06%-127.16M	5.00%-28.16M	-137.29%-32.87M	-21.82%-34.35M	-5.93%-31.79M	100.38%322K	-42.91%-29.64M	369.00%88.16M	-56.12%-28.19M	-110.91%-30.01M
Net income from continuing operations	-222.91%-93.8M	11.46%-28.03M	-125.02%-18.88M	68.64%-11.95M	-0.53%-34.94M	72.83%-29.05M	-11.91%-31.66M	344.27%75.46M	-44.79%-38.09M	-62.29%-34.76M
Operating gains losses	126.17%78K	110.29%7K	111.70%11K	93.75%-6K	265.00%66K	-927.78%-298K	-361.54%-68K	-508.70%-94K	-442.86%-96K	2.44%-40K
Depreciation and amortization	-1.37%1.95M	11.21%506K	2.89%498K	-3.25%506K	-14.53%441K	34.47%1.98M	23.64%455K	31.17%484K	26.94%523K	60.25%516K
Deferred tax	----	----	--0	--0	--0	----	----	-55.03%-1.25M	-186.28%-1.29M	-655.75%-1.32M
Other non cash items	-0.54%2.19M	-1.07%557K	-0.18%551K	-0.37%545K	-0.55%541K	17.78%2.21M	-9.92%563K	10.40%552K	45.09%547K	46.63%544K
Change In working capital	-787.64%-55.18M	8.17%-5.9M	-324.24%-19.55M	-605.69%-27.62M	-883.70%-2.12M	67.54%8.03M	-645.33%-6.42M	253.14%8.72M	16.76%5.46M	-94.16%270K
-Change in receivables	84.40%-216K	-108.23%-775K	114.86%1.55M	11,586.67%1.75M	-578.47%-2.74M	-146.20%-1.39M	7,020.59%9.41M	-424.74%-10.41M	101.76%15K	-151.86%-404K
-Change in prepaid assets	63.41%969K	1,066.27%802K	43.61%-1.35M	-72.07%188K	-44.56%1.33M	1,953.13%593K	-103.47%-83K	66.00%-2.4M	-63.14%673K	-14.20%2.4M
-Change in payables and accrued expense	-517.87%-9.98M	352.33%5.64M	-19,487.36%-17.04M	-100.14%-8K	256.69%1.43M	-79.79%2.39M	-132.74%-2.23M	87.71%-87K	32.53%5.62M	-162.21%-912K
-Change in other current assets	13.48%101K	--1K	--11K	--0	--89K	129.87%89K	--0	--0	--89K	--0
-Change in other current liabilities	-45.13%-2.22M	-43.80%-568K	-17.12%-554K	-114.73%-554K	-34.81%-546K	-50.10%-1.53M	-50.76%-395K	-90.73%-473K	1.15%-258K	-62.65%-405K
-Change in other working capital	-656.95%-43.83M	16.21%-11M	-109.78%-2.16M	-4,170.99%-29M	-311.03%-1.68M	190.66%7.87M	-64.92%-13.12M	8,042.81%22.08M	-143.37%-679K	-145.78%-408K
Cash from discontinued investing activities
Operating cash flow	-39,590.06%-127.16M	5.00%-28.16M	-137.29%-32.87M	-21.82%-34.35M	-5.93%-31.79M	100.38%322K	-42.91%-29.64M	369.00%88.16M	-56.12%-28.19M	-110.91%-30.01M
Investing cash flow
Cash flow from continuing investing activities	144.40%78.04M	-6.40%31.88M	111.73%24.5M	2,265.78%28.35M	-1,759.06%-6.69M	-10,387.95%-175.78M	8,657.29%34.06M	-53,609.51%-208.93M	-1,018.80%-1.31M	152.20%403K
Net PPE purchase and sale	-221.93%-1.94M	-123.14%-398K	--0	32.12%-1.07M	2.46%-475K	63.52%-602K	1,476.00%1.72M	17.90%-266K	-265.73%-1.57M	36.92%-487K
Net investment purchase and sale	145.66%79.98M	-0.19%32.28M	111.74%24.5M	11,213.46%29.42M	-797.87%-6.21M	-673,653.85%-175.18M	11,945.42%32.34M	-320,921.54%-208.66M	-16.67%260K	--890K
Cash from discontinued investing activities
Investing cash flow	144.40%78.04M	-6.40%31.88M	111.73%24.5M	2,265.78%28.35M	-1,759.06%-6.69M	-10,387.95%-175.78M	8,657.29%34.06M	-53,609.51%-208.93M	-1,018.80%-1.31M	152.20%403K
Financing cash flow
Cash flow from continuing financing activities	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-99.08%880K	-99.83%165K	-25.90%269K	-54.34%205K	31.69%241K
Proceeds from stock option exercised by employees	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-30.65%880K	-39.78%165K	-25.90%269K	-54.34%205K	31.69%241K
Cash from discontinued financing activities
Financing cash flow	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-99.08%880K	-99.83%165K	-25.90%269K	-54.34%205K	31.69%241K
Net cash flow
Beginning cash position	-52.30%159.52M	-30.81%107.37M	-58.11%115.54M	-60.19%121.46M	-52.30%159.52M	2.46%334.43M	-40.54%155.19M	-6.13%275.83M	-2.08%305.14M	2.46%334.43M
Current changes in cash	72.35%-48.28M	-16.53%3.83M	93.29%-8.09M	79.67%-5.96M	-29.62%-38.06M	-2,259.26%-174.58M	-93.75%4.59M	-267.40%-120.5M	-65.28%-29.3M	-98.18%-29.36M
Effect of exchange rate changes	106.67%22K	127.73%71K	37.86%-87K	880.00%39K	-101.41%-1K	-511.11%-330K	-4,366.67%-256K	-137.29%-140K	85.71%-5K	108.82%71K
End cash Position	-30.25%111.27M	-30.25%111.27M	-30.81%107.37M	-58.11%115.54M	-60.19%121.46M	-52.30%159.52M	-52.30%159.52M	-40.54%155.19M	-6.13%275.83M	-2.08%305.14M
Free cash flow	-46,005.71%-129.1M	-2.28%-28.55M	-137.40%-32.87M	-18.98%-35.41M	-5.80%-32.26M	99.68%-280K	-33.55%-27.92M	365.56%87.89M	-60.99%-29.76M	-103.30%-30.49M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall